The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global β-Nicotinamide Adenine Dinucleotide Market Research Report 2025

Global β-Nicotinamide Adenine Dinucleotide Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1765027

No of Pages : 94

Synopsis
Global β-Nicotinamide Adenine Dinucleotide market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole β-Nicotinamide Adenine Dinucleotide market research.

Key manufacturers engaged in the β-Nicotinamide Adenine Dinucleotide industry include Maintain Biotech, Gihi Chemicals, Weitai Bio-Pharmaceutical, Anhui Rencheng Technology, SyncoZymes, Shaanxi Cuikang Pharmaceutical Technology, Wuhan ShuEr Biology Technology, Xi’an Sengmei Biotech and Hebei Bonster Technology, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

For production bases, global β-Nicotinamide Adenine Dinucleotide production is dominated by and . The two regions contributed to % production share globally in 2022.

When refers to consumption region, % volume of β-Nicotinamide Adenine Dinucleotide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole β-Nicotinamide Adenine Dinucleotide market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global β-Nicotinamide Adenine Dinucleotide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Maintain Biotech
  • Gihi Chemicals
  • Weitai Bio-Pharmaceutical
  • Anhui Rencheng Technology
  • SyncoZymes
  • Shaanxi Cuikang Pharmaceutical Technology
  • Wuhan ShuEr Biology Technology
  • Xi’an Sengmei Biotech
  • Hebei Bonster Technology
  • Hebei Lingding Biological Technology
  • Wuhan wingroup Pharmaceutical
  • Jiangsu Bangdeya New Material
  • Zhuoer Chemical

Segment by Type

  • 95%~98%
  • 98%~99%
  • >99%

Segment by Application

  • Pharmacy
  • Food and Beverage
  • Others

Production by Region

  • North America
  • Europe
  • China
  • Japan

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The β-Nicotinamide Adenine Dinucleotide report covers below items:

Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source

Index

1 β-Nicotinamide Adenine Dinucleotide Market Overview
1.1 Product Definition
1.2 β-Nicotinamide Adenine Dinucleotide Segment by Type
1.2.1 Global β-Nicotinamide Adenine Dinucleotide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 95%~98%
1.2.3 98%~99%
1.2.4 >99%
1.3 β-Nicotinamide Adenine Dinucleotide Segment by Application
1.3.1 Global β-Nicotinamide Adenine Dinucleotide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Food and Beverage
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global β-Nicotinamide Adenine Dinucleotide Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global β-Nicotinamide Adenine Dinucleotide Production Estimates and Forecasts (2018-2029)
1.4.4 Global β-Nicotinamide Adenine Dinucleotide Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global β-Nicotinamide Adenine Dinucleotide Production Market Share by Manufacturers (2018-2023)
2.2 Global β-Nicotinamide Adenine Dinucleotide Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of β-Nicotinamide Adenine Dinucleotide, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global β-Nicotinamide Adenine Dinucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global β-Nicotinamide Adenine Dinucleotide Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of β-Nicotinamide Adenine Dinucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of β-Nicotinamide Adenine Dinucleotide, Product Offered and Application
2.8 Global Key Manufacturers of β-Nicotinamide Adenine Dinucleotide, Date of Enter into This Industry
2.9 β-Nicotinamide Adenine Dinucleotide Market Competitive Situation and Trends
2.9.1 β-Nicotinamide Adenine Dinucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest β-Nicotinamide Adenine Dinucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 β-Nicotinamide Adenine Dinucleotide Production by Region
3.1 Global β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global β-Nicotinamide Adenine Dinucleotide Production Value by Region (2018-2029)
3.2.1 Global β-Nicotinamide Adenine Dinucleotide Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of β-Nicotinamide Adenine Dinucleotide by Region (2024-2029)
3.3 Global β-Nicotinamide Adenine Dinucleotide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global β-Nicotinamide Adenine Dinucleotide Production by Region (2018-2029)
3.4.1 Global β-Nicotinamide Adenine Dinucleotide Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of β-Nicotinamide Adenine Dinucleotide by Region (2024-2029)
3.5 Global β-Nicotinamide Adenine Dinucleotide Market Price Analysis by Region (2018-2023)
3.6 Global β-Nicotinamide Adenine Dinucleotide Production and Value, Year-over-Year Growth
3.6.1 North America β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.3 China β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan β-Nicotinamide Adenine Dinucleotide Production Value Estimates and Forecasts (2018-2029)
4 β-Nicotinamide Adenine Dinucleotide Consumption by Region
4.1 Global β-Nicotinamide Adenine Dinucleotide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global β-Nicotinamide Adenine Dinucleotide Consumption by Region (2018-2029)
4.2.1 Global β-Nicotinamide Adenine Dinucleotide Consumption by Region (2018-2023)
4.2.2 Global β-Nicotinamide Adenine Dinucleotide Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America β-Nicotinamide Adenine Dinucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America β-Nicotinamide Adenine Dinucleotide Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe β-Nicotinamide Adenine Dinucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe β-Nicotinamide Adenine Dinucleotide Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific β-Nicotinamide Adenine Dinucleotide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific β-Nicotinamide Adenine Dinucleotide Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa β-Nicotinamide Adenine Dinucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa β-Nicotinamide Adenine Dinucleotide Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global β-Nicotinamide Adenine Dinucleotide Production by Type (2018-2029)
5.1.1 Global β-Nicotinamide Adenine Dinucleotide Production by Type (2018-2023)
5.1.2 Global β-Nicotinamide Adenine Dinucleotide Production by Type (2024-2029)
5.1.3 Global β-Nicotinamide Adenine Dinucleotide Production Market Share by Type (2018-2029)
5.2 Global β-Nicotinamide Adenine Dinucleotide Production Value by Type (2018-2029)
5.2.1 Global β-Nicotinamide Adenine Dinucleotide Production Value by Type (2018-2023)
5.2.2 Global β-Nicotinamide Adenine Dinucleotide Production Value by Type (2024-2029)
5.2.3 Global β-Nicotinamide Adenine Dinucleotide Production Value Market Share by Type (2018-2029)
5.3 Global β-Nicotinamide Adenine Dinucleotide Price by Type (2018-2029)
6 Segment by Application
6.1 Global β-Nicotinamide Adenine Dinucleotide Production by Application (2018-2029)
6.1.1 Global β-Nicotinamide Adenine Dinucleotide Production by Application (2018-2023)
6.1.2 Global β-Nicotinamide Adenine Dinucleotide Production by Application (2024-2029)
6.1.3 Global β-Nicotinamide Adenine Dinucleotide Production Market Share by Application (2018-2029)
6.2 Global β-Nicotinamide Adenine Dinucleotide Production Value by Application (2018-2029)
6.2.1 Global β-Nicotinamide Adenine Dinucleotide Production Value by Application (2018-2023)
6.2.2 Global β-Nicotinamide Adenine Dinucleotide Production Value by Application (2024-2029)
6.2.3 Global β-Nicotinamide Adenine Dinucleotide Production Value Market Share by Application (2018-2029)
6.3 Global β-Nicotinamide Adenine Dinucleotide Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Maintain Biotech
7.1.1 Maintain Biotech β-Nicotinamide Adenine Dinucleotide Corporation Information
7.1.2 Maintain Biotech β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.1.3 Maintain Biotech β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Maintain Biotech Main Business and Markets Served
7.1.5 Maintain Biotech Recent Developments/Updates
7.2 Gihi Chemicals
7.2.1 Gihi Chemicals β-Nicotinamide Adenine Dinucleotide Corporation Information
7.2.2 Gihi Chemicals β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.2.3 Gihi Chemicals β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Gihi Chemicals Main Business and Markets Served
7.2.5 Gihi Chemicals Recent Developments/Updates
7.3 Weitai Bio-Pharmaceutical
7.3.1 Weitai Bio-Pharmaceutical β-Nicotinamide Adenine Dinucleotide Corporation Information
7.3.2 Weitai Bio-Pharmaceutical β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.3.3 Weitai Bio-Pharmaceutical β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Weitai Bio-Pharmaceutical Main Business and Markets Served
7.3.5 Weitai Bio-Pharmaceutical Recent Developments/Updates
7.4 Anhui Rencheng Technology
7.4.1 Anhui Rencheng Technology β-Nicotinamide Adenine Dinucleotide Corporation Information
7.4.2 Anhui Rencheng Technology β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.4.3 Anhui Rencheng Technology β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Anhui Rencheng Technology Main Business and Markets Served
7.4.5 Anhui Rencheng Technology Recent Developments/Updates
7.5 SyncoZymes
7.5.1 SyncoZymes β-Nicotinamide Adenine Dinucleotide Corporation Information
7.5.2 SyncoZymes β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.5.3 SyncoZymes β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.5.4 SyncoZymes Main Business and Markets Served
7.5.5 SyncoZymes Recent Developments/Updates
7.6 Shaanxi Cuikang Pharmaceutical Technology
7.6.1 Shaanxi Cuikang Pharmaceutical Technology β-Nicotinamide Adenine Dinucleotide Corporation Information
7.6.2 Shaanxi Cuikang Pharmaceutical Technology β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.6.3 Shaanxi Cuikang Pharmaceutical Technology β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Shaanxi Cuikang Pharmaceutical Technology Main Business and Markets Served
7.6.5 Shaanxi Cuikang Pharmaceutical Technology Recent Developments/Updates
7.7 Wuhan ShuEr Biology Technology
7.7.1 Wuhan ShuEr Biology Technology β-Nicotinamide Adenine Dinucleotide Corporation Information
7.7.2 Wuhan ShuEr Biology Technology β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.7.3 Wuhan ShuEr Biology Technology β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Wuhan ShuEr Biology Technology Main Business and Markets Served
7.7.5 Wuhan ShuEr Biology Technology Recent Developments/Updates
7.8 Xi’an Sengmei Biotech
7.8.1 Xi’an Sengmei Biotech β-Nicotinamide Adenine Dinucleotide Corporation Information
7.8.2 Xi’an Sengmei Biotech β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.8.3 Xi’an Sengmei Biotech β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Xi’an Sengmei Biotech Main Business and Markets Served
7.7.5 Xi’an Sengmei Biotech Recent Developments/Updates
7.9 Hebei Bonster Technology
7.9.1 Hebei Bonster Technology β-Nicotinamide Adenine Dinucleotide Corporation Information
7.9.2 Hebei Bonster Technology β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.9.3 Hebei Bonster Technology β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Hebei Bonster Technology Main Business and Markets Served
7.9.5 Hebei Bonster Technology Recent Developments/Updates
7.10 Hebei Lingding Biological Technology
7.10.1 Hebei Lingding Biological Technology β-Nicotinamide Adenine Dinucleotide Corporation Information
7.10.2 Hebei Lingding Biological Technology β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.10.3 Hebei Lingding Biological Technology β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Hebei Lingding Biological Technology Main Business and Markets Served
7.10.5 Hebei Lingding Biological Technology Recent Developments/Updates
7.11 Wuhan wingroup Pharmaceutical
7.11.1 Wuhan wingroup Pharmaceutical β-Nicotinamide Adenine Dinucleotide Corporation Information
7.11.2 Wuhan wingroup Pharmaceutical β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.11.3 Wuhan wingroup Pharmaceutical β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Wuhan wingroup Pharmaceutical Main Business and Markets Served
7.11.5 Wuhan wingroup Pharmaceutical Recent Developments/Updates
7.12 Jiangsu Bangdeya New Material
7.12.1 Jiangsu Bangdeya New Material β-Nicotinamide Adenine Dinucleotide Corporation Information
7.12.2 Jiangsu Bangdeya New Material β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.12.3 Jiangsu Bangdeya New Material β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Jiangsu Bangdeya New Material Main Business and Markets Served
7.12.5 Jiangsu Bangdeya New Material Recent Developments/Updates
7.13 Zhuoer Chemical
7.13.1 Zhuoer Chemical β-Nicotinamide Adenine Dinucleotide Corporation Information
7.13.2 Zhuoer Chemical β-Nicotinamide Adenine Dinucleotide Product Portfolio
7.13.3 Zhuoer Chemical β-Nicotinamide Adenine Dinucleotide Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Zhuoer Chemical Main Business and Markets Served
7.13.5 Zhuoer Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 β-Nicotinamide Adenine Dinucleotide Industry Chain Analysis
8.2 β-Nicotinamide Adenine Dinucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 β-Nicotinamide Adenine Dinucleotide Production Mode & Process
8.4 β-Nicotinamide Adenine Dinucleotide Sales and Marketing
8.4.1 β-Nicotinamide Adenine Dinucleotide Sales Channels
8.4.2 β-Nicotinamide Adenine Dinucleotide Distributors
8.5 β-Nicotinamide Adenine Dinucleotide Customers
9 β-Nicotinamide Adenine Dinucleotide Market Dynamics
9.1 β-Nicotinamide Adenine Dinucleotide Industry Trends
9.2 β-Nicotinamide Adenine Dinucleotide Market Drivers
9.3 β-Nicotinamide Adenine Dinucleotide Market Challenges
9.4 β-Nicotinamide Adenine Dinucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’